Amitriptylinoxide | CAS#4317-14-0 | Antidepressive

Amitriptylinoxide
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 592771

CAS#: 4317-14-0

Description: Amitriptylinoxide is an antidepressant.

Chemical Structure

Amitriptylinoxide

CAS# 4317-14-0

Instruction

Theoretical Analysis

MedKoo Cat#: 592771
Name: Amitriptylinoxide
CAS#: 4317-14-0
Chemical Formula: C20H23NO
Exact Mass: 293.18
Molecular Weight: 293.410
Elemental Analysis: C, 81.87; H, 7.90; N, 4.77; O, 5.45

Price and Availability

Size	Price	Availability
50mg	USD 350	2 Weeks
250mg	USD 950	2 Weeks
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Synonym: Amitriptylinoxide

IUPAC/Chemical Name: 10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,d)cycloheptene-delta(sup 5,gamma)-propylamine N-oxide

InChi Key: ZPMKQFOGINQDAM-UHFFFAOYSA-N

InChi Code: InChI=1S/C20H23NO/c1-21(2,22)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3

SMILES Code: C[N+](CC/C=C1C2=C(CCC3=C\1C=CC=C3)C=CC=C2)([O-])C

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Instruction:

View handling instruction

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 293.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: Azanza JR, Sádada B, Reis J. Liposomal formulations of amphotericin B: differences according to the scientific evidence. Rev Esp Quimioter. 2015 Dec;28(6):275-81. Review. PubMed PMID: 26621170.

2: Houdek MT, Greenwood-Quaintance KE, Morrey ME, Patel R, Hanssen AD. Elution of High Dose Amphotericin B Deoxycholate From Polymethylmethacrylate. J Arthroplasty. 2015 Dec;30(12):2308-10. doi: 10.1016/j.arth.2015.06.002. Epub 2015 Jun 11. PubMed PMID: 26162513.

3: Kumar R, Sahoo GC, Pandey K, Das V, Das P. Study the effects of PLGA-PEG encapsulated amphotericin B nanoparticle drug delivery system against Leishmania donovani. Drug Deliv. 2015 May;22(3):383-8. doi: 10.3109/10717544.2014.891271. Epub 2014 Mar 6. PubMed PMID: 24601828.

4: Undre NA, Stevenson P, Wilbraham D. Pharmacokinetic profile of micafungin when co-administered with amphotericin B in healthy male subjects. Int J Clin Pharmacol Ther. 2014 Mar;52(3):237-44. doi: 10.5414/CP202015. PubMed PMID: 24472403.

5: Belhachemi MH, Boucherit K, Boucherit-Otmani Z, Belmir S, Benbekhti Z. Effects of ascorbic acid and α-tocopherol on the therapeutic index of amphotericin B. J Mycol Med. 2014 Dec;24(4):e137-42. doi: 10.1016/j.mycmed.2014.04.003. Epub 2014 Oct 16. PubMed PMID: 25442914.

6: Hamill RJ. Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs. 2013 Jun;73(9):919-34. doi: 10.1007/s40265-013-0069-4. Review. PubMed PMID: 23729001.

7: Ohata Y, Tomita Y, Suzuki K, Maniwa T, Yano Y, Sunakawa K. Pharmacokinetic evaluation of liposomal amphotericin B (L-AMB) in patients with invasive fungal infection: Population approach in Japanese pediatrics. Drug Metab Pharmacokinet. 2015 Dec;30(6):400-9. doi: 10.1016/j.dmpk.2015.08.003. Epub 2015 Aug 28. PubMed PMID: 26645511.

8: Souza AC, Nascimento AL, de Vasconcelos NM, Jerônimo MS, Siqueira IM, R-Santos L, Cintra DO, Fuscaldi LL, Pires Júnior OR, Titze-de-Almeida R, Borin MF, Báo SN, Martins OP, Cardoso VN, Fernandes SO, Mortari MR, Tedesco AC, Amaral AC, Felipe MS, Bocca AL. Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles. Eur J Med Chem. 2015 May 5;95:267-76. doi: 10.1016/j.ejmech.2015.03.022. Epub 2015 Mar 14. PubMed PMID: 25827397.

9: Janout V, Schell WA, Thévenin D, Yu Y, Perfect JR, Regen SL. Taming Amphotericin B. Bioconjug Chem. 2015 Oct 21;26(10):2021-4. doi: 10.1021/acs.bioconjchem.5b00463. Epub 2015 Sep 10. PubMed PMID: 26340430.

10: Al-Saigh R, Siopi M, Siafakas N, Velegraki A, Zerva L, Meletiadis J. Single-dose pharmacodynamics of amphotericin B against Aspergillus species in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother. 2013 Aug;57(8):3713-8. doi: 10.1128/AAC.02484-12. Epub 2013 May 28. PubMed PMID: 23716054; PubMed Central PMCID: PMC3719712.

11: Berman J. Amphotericin B formulations and other drugs for visceral leishmaniasis. Am J Trop Med Hyg. 2015 Mar;92(3):471-3. doi: 10.4269/ajtmh.14-0743. Epub 2014 Dec 15. PubMed PMID: 25510726; PubMed Central PMCID: PMC4350529.

12: Mishra J, Dey A, Singh N, Somvanshi R, Singh S. Evaluation of toxicity & therapeutic efficacy of a new liposomal formulation of amphotericin B in a mouse model. Indian J Med Res. 2013 Apr;137(4):767-76. PubMed PMID: 23703346; PubMed Central PMCID: PMC3724259.

13: Al-Quadeib BT, Radwan MA, Siller L, Mutch E, Horrocks B, Wright M, Alshaer A. Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay. Biomed Chromatogr. 2014 Dec;28(12):1652-9. doi: 10.1002/bmc.3198. Epub 2014 Apr 14. PubMed PMID: 24733605.

14: Ickowicz DE, Farber S, Sionov E, Kagan S, Hoffman A, Polacheck I, Domb AJ. Activity, reduced toxicity, and scale-up synthesis of amphotericin B-conjugated polysaccharide. Biomacromolecules. 2014 Jun 9;15(6):2079-89. doi: 10.1021/bm5002125. Epub 2014 May 16. PubMed PMID: 24779556.

15: Bhatia S, Kumar V, Sharma K, Nagpal K, Bera T. Significance of algal polymer in designing amphotericin B nanoparticles. ScientificWorldJournal. 2014;2014:564573. doi: 10.1155/2014/564573. Epub 2014 Nov 12. PubMed PMID: 25478596; PubMed Central PMCID: PMC4244925.

16: Mudavath SL, Talat M, Rai M, Srivastava ON, Sundar S. Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies. Drug Des Devel Ther. 2014 Sep 4;8:1235-47. doi: 10.2147/DDDT.S63994. eCollection 2014. PubMed PMID: 25214767; PubMed Central PMCID: PMC4159315.

17: Kaur L, Jain SK, Manhas RK, Sharma D. Nanoethosomal formulation for skin targeting of amphotericin B: an in vitro and in vivo assessment. J Liposome Res. 2015;25(4):294-307. doi: 10.3109/08982104.2014.995670. Epub 2014 Dec 30. PubMed PMID: 25547800.

18: Asthana S, Gupta PK, Jaiswal AK, Dube A, Chourasia MK. Targeted chemotherapy of visceral leishmaniasis by lactoferrin-appended amphotericin B-loaded nanoreservoir: in vitro and in vivo studies. Nanomedicine (Lond). 2015;10(7):1093-109. doi: 10.2217/nnm.14.182. PubMed PMID: 25929567.

19: Adler-Moore JP, Gangneux JP, Pappas PG. Comparison between liposomal formulations of amphotericin B. Med Mycol. 2016 Mar;54(3):223-31. doi: 10.1093/mmy/myv111. Epub 2016 Jan 14. Review. PubMed PMID: 26768369.

20: Gangadhar KN, Adhikari K, Srichana T. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation. Int J Pharm. 2014 Aug 25;471(1-2):430-8. doi: 10.1016/j.ijpharm.2014.05.066. Epub 2014 Jun 4. PubMed PMID: 24907597.

Your view history

Amitriptylinoxide featured